Compare SOUN & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOUN | TWST |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | United States | United States |
| Employees | 954 | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.0B |
| IPO Year | N/A | 2018 |
| Metric | SOUN | TWST |
|---|---|---|
| Price | $8.45 | $53.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | $15.00 | ★ $46.88 |
| AVG Volume (30 Days) | ★ 27.7M | 1.3M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $376,572,000.00 |
| Revenue This Year | $40.76 | $18.91 |
| Revenue Next Year | $20.02 | $15.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $5.83 | $23.30 |
| 52 Week High | $22.17 | $66.06 |
| Indicator | SOUN | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 52.06 | 49.43 |
| Support Level | $7.43 | $41.85 |
| Resistance Level | $9.08 | $57.88 |
| Average True Range (ATR) | 0.57 | 3.53 |
| MACD | -0.09 | -1.04 |
| Stochastic Oscillator | 26.88 | 47.88 |
SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.